Cipla
EZHILARASAN S is a Senior Executive at Cipla since March 2025, with prior experience as a Shift Incharge Production Executive at Sami-Sabinsa Group Limited from May 2023 to February 2025, specializing in Super Critical Fluid Extraction. Previous roles include Executive Trainee at Anthem Biosciences Private Limited, where responsibilities encompassed batch execution, adherence to cGMP and safety practices, and environmental management. Additional experience includes serving as Contract Incharge at Hikal Ltd for ETP and related operations, and as Shift Incharge at Enviros India Pvt Ltd overseeing electrolysis ETP. EZHILARASAN holds a Bachelor of Engineering in Petrochemical Engineering from Anna University Chennai, graduated in 2020.
Previous companies
This person is not in any teams
This person is not in any offices
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.